Matthew C Canver1,2, Daniel E Bauer3,4,5, Takahiro Maeda6, Luca Pinello1,2,7. 1. Molecular Pathology Unit, Center for Computational and Integrative Biology, Center for Cancer Research, Massachusetts General Hospital, Charlestown, MA, USA. 2. Department of Pathology, Harvard Medical School, Boston, MA, USA. 3. Division of Hematology/Oncology, Boston Children's Hospital, Boston, USA. 4. Department of Pediatric Oncology, Dana-Farber Cancer Institute, Harvard Stem Cell Institute, Boston, USA. 5. Department of Pediatrics, Harvard Medical School, Boston, MA, USA. 6. Center for Cellular and Molecular Medicine, Kyushu University Hospital, Fukuoka, Japan. 7. Broad Institute of MIT and Harvard, Cambridge, MA, USA.
Abstract
MOTIVATION: The clustered regularly interspaced short palindromic repeats (CRISPR)/CRISPR-associated (Cas) nuclease system has allowed for high-throughput, large scale pooled screens for functional genomic studies. To aid in the translation of functional genomics to therapeutics, we developed DrugThatGene (DTG) as a web-based application that streamlines analysis of potential therapeutic targets identified from functional genetic screens. RESULTS: Starting from a gene list as input, DTG offers automated identification of small molecules along with supporting information from human genetic and other relevant databases. Furthermore, DTG aids in the identification of common biological pathways and protein complexes in conjunction with associated small molecule inhibitors. Taken together, DTG aims to expedite the identification of small molecules from the abundance of functional genetic data generated from CRISPR screens. AVAILABILITY AND IMPLEMENTATION: DTG is an open-source and free software available as a website at http://drugthatgene.pinellolab.org. Source code is available at: https://github.com/pinellolab/DrugThatGene, which can be downloaded in order to run DTG locally.
MOTIVATION: The clustered regularly interspaced short palindromic repeats (CRISPR)/CRISPR-associated (Cas) nuclease system has allowed for high-throughput, large scale pooled screens for functional genomic studies. To aid in the translation of functional genomics to therapeutics, we developed DrugThatGene (DTG) as a web-based application that streamlines analysis of potential therapeutic targets identified from functional genetic screens. RESULTS: Starting from a gene list as input, DTG offers automated identification of small molecules along with supporting information from human genetic and other relevant databases. Furthermore, DTG aids in the identification of common biological pathways and protein complexes in conjunction with associated small molecule inhibitors. Taken together, DTG aims to expedite the identification of small molecules from the abundance of functional genetic data generated from CRISPR screens. AVAILABILITY AND IMPLEMENTATION:DTG is an open-source and free software available as a website at http://drugthatgene.pinellolab.org. Source code is available at: https://github.com/pinellolab/DrugThatGene, which can be downloaded in order to run DTG locally.
Authors: Ada Hamosh; Alan F Scott; Joanna Amberger; Carol Bocchini; David Valle; Victor A McKusick Journal: Nucleic Acids Res Date: 2002-01-01 Impact factor: 16.971
Authors: Ophir Shalem; Neville E Sanjana; Ella Hartenian; Xi Shi; David A Scott; Tarjei Mikkelson; Dirk Heckl; Benjamin L Ebert; David E Root; John G Doench; Feng Zhang Journal: Science Date: 2013-12-12 Impact factor: 47.728
Authors: Benjamin E Housden; Alexander J Valvezan; Colleen Kelley; Richelle Sopko; Yanhui Hu; Charles Roesel; Shuailiang Lin; Michael Buckner; Rong Tao; Bahar Yilmazel; Stephanie E Mohr; Brendan D Manning; Norbert Perrimon Journal: Sci Signal Date: 2015-09-08 Impact factor: 8.192
Authors: Christian von Mering; Lars J Jensen; Berend Snel; Sean D Hooper; Markus Krupp; Mathilde Foglierini; Nelly Jouffre; Martijn A Huynen; Peer Bork Journal: Nucleic Acids Res Date: 2005-01-01 Impact factor: 16.971
Authors: Junwei Shi; Eric Wang; Joseph P Milazzo; Zihua Wang; Justin B Kinney; Christopher R Vakoc Journal: Nat Biotechnol Date: 2015-05-11 Impact factor: 54.908
Authors: Malachi Griffith; Obi L Griffith; Adam C Coffman; James V Weible; Josh F McMichael; Nicholas C Spies; James Koval; Indraniel Das; Matthew B Callaway; James M Eldred; Christopher A Miller; Janakiraman Subramanian; Ramaswamy Govindan; Runjun D Kumar; Ron Bose; Li Ding; Jason R Walker; David E Larson; David J Dooling; Scott M Smith; Timothy J Ley; Elaine R Mardis; Richard K Wilson Journal: Nat Methods Date: 2013-10-13 Impact factor: 28.547
Authors: Wei Li; Han Xu; Tengfei Xiao; Le Cong; Michael I Love; Feng Zhang; Rafael A Irizarry; Jun S Liu; Myles Brown; X Shirley Liu Journal: Genome Biol Date: 2014 Impact factor: 13.583
Authors: Melissa J Landrum; Jennifer M Lee; George R Riley; Wonhee Jang; Wendy S Rubinstein; Deanna M Church; Donna R Maglott Journal: Nucleic Acids Res Date: 2013-11-14 Impact factor: 16.971
Authors: Wei Feng Ma; Chani J Hodonsky; Adam W Turner; Doris Wong; Yipei Song; Jose Verdezoto Mosquera; Alexandra V Ligay; Lotte Slenders; Christina Gancayco; Huize Pan; Nelson B Barrientos; David Mai; Gabriel F Alencar; Katherine Owsiany; Gary K Owens; Muredach P Reilly; Mingyao Li; Gerard Pasterkamp; Michal Mokry; Sander W van der Laan; Bohdan B Khomtchouk; Clint L Miller Journal: Atherosclerosis Date: 2021-11-26 Impact factor: 5.162